The Oncogenic RAS2(val19) Mutation Locks Respiration, Independently of PKA, in a Mode Prone to Generate ROS
Overview
Molecular Biology
Affiliations
The RAS2(val19) allele, which renders the cAMP-PKA pathway constitutively active and decreases the replicative life-span of yeast cells, is demonstrated to increase production of reactive oxygen species (ROS) and to elevate oxidative protein damage. Mitochondrial respiration in the mutant is locked in a non-phosphorylating mode prone to generate ROS but this phenotype is not linked to a constitutively active PKA pathway. In contrast, providing RAS2(val19) cells with the mammalian uncoupling protein UCP1 restores phosphorylating respiration and reduces ROS levels, but does not correct for PKA-dependent defects. Thus, the RAS2(val19) allele acts like a double-edged sword with respect to oxidation management: (i). it diminishes expression of STRE element genes required for oxidative stress defenses in a PKA-dependent fashion, and (ii). it affects endogenous ROS production and the respiratory state in a PKA-independent way. The effect of the oncogenic RAS allele on the replicative life-span is primarily asserted via the PKA-dependent pathway since Pde2p, but not UCP1, overproduction suppressed premature aging of the RAS2(val19) mutant.
Peralta-Ruiz Y, Hernandez J, Grande-Tovar C, Serio A, Valbonetti L, Chaves-Lopez C Molecules. 2024; 29(15).
PMID: 39124920 PMC: 11314608. DOI: 10.3390/molecules29153516.
Gender Differences in Oxidative Stress in Relation to Cancer Susceptibility and Survival.
Allegra A, Caserta S, Genovese S, Pioggia G, Gangemi S Antioxidants (Basel). 2023; 12(6).
PMID: 37371985 PMC: 10295142. DOI: 10.3390/antiox12061255.
Modulation of Nrf2/HO-1 by Natural Compounds in Lung Cancer.
Ghareghomi S, Moosavi-Movahedi F, Saso L, Habibi-Rezaei M, Khatibi A, Hong J Antioxidants (Basel). 2023; 12(3).
PMID: 36978983 PMC: 10044870. DOI: 10.3390/antiox12030735.
Horibe S, Ishikawa K, Nakada K, Wake M, Takeda N, Tanaka T Oncol Rep. 2021; 47(2).
PMID: 34935060 PMC: 8717125. DOI: 10.3892/or.2021.8243.
Senescent tumor cells: an overlooked adversary in the battle against cancer.
Park S, Choi Y, Kim J, Kim H, Park T Exp Mol Med. 2021; 53(12):1834-1841.
PMID: 34916607 PMC: 8741813. DOI: 10.1038/s12276-021-00717-5.